{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:25:27Z","timestamp":1777577127593,"version":"3.51.4"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Because of the bioterrorism threat posed by agents such as variola virus, considerable time, resources, and effort have been devoted to biodefense preparation. One avenue of this research has been the development of rapid, sensitive, high-throughput assays to validate immune responses to poxviruses. Here we describe the adaptation of a \u03b2-galactosidase reporter-based vaccinia virus neutralization assay to large-scale use in a study that included over 1,000 subjects. We also describe the statistical methods involved in analyzing the large quantity of data generated. The assay and its associated methods should prove useful tools in monitoring immune responses to next-generation smallpox vaccines, studying poxvirus immunity, and evaluating therapeutic agents such as vaccinia virus immune globulin.<\/jats:p>","DOI":"10.1128\/cvi.00109-09","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T01:27:51Z","timestamp":1245288471000},"page":"1105-1112","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Statistical Approach To Estimate Vaccinia-Specific Neutralizing Antibody Titers Using a High-Throughput Assay"],"prefix":"10.1128","volume":"16","author":[{"given":"Richard","family":"Kennedy","sequence":"first","affiliation":[{"name":"Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Shane","family":"Pankratz","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Swanson","sequence":"additional","affiliation":[{"name":"Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Watson","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[{"name":"Division of Viral Products, CBER, Food and Drug Administration, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[{"name":"Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota 55905"},{"name":"Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","volume":"211","year":"2006","unstructured":"Amanna, I. J., M. K. Slifka, and S. Crotty. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev.211:320-337.","journal-title":"Immunol. Rev."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/380906","volume":"189","year":"2004","unstructured":"Belshe, R. B., F. K. Newman, S. E. Frey, R. B. Couch, J. J. Treanor, C. O. Tacket, and L. Yan. 2004. Dose-dependent neutralizing-antibody responses to vaccinia. J. Infect. Dis.189:493-497.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.taap.2004.03.009","volume":"199","year":"2004","unstructured":"Bhalla, D. K., and D. B. Warheit. 2004. Biological agents with potential for misuse: a historical perspective and defensive measures. Toxicol. Appl. Pharmacol.199:71-84.","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-2143(03)00143-4","volume":"142","year":"2003","unstructured":"Bonilla-Guerrero, R., and G. A. Poland. 2003. Smallpox vaccines: current and future. J. Lab. Clin. Med.142:252-257.","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biologicals.2007.07.001","volume":"36","year":"2008","unstructured":"Borges, M. B., S. E. Kato, C. R. Damaso, N. Moussatche, M. da Silva Freire, S. R. Lambert Passos, and J. P. do Nascimento. 2008. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies. Biologicals36:105-110.","journal-title":"Biologicals"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00018-006-6308-z","volume":"63","year":"2006","unstructured":"Bossi, P., D. Garin, A. Guihot, F. Gay, J. M. Crance, T. Debord, B. Autran, and F. Bricaire. 2006. Bioterrorism: management of major biological agents. Cell. Mol. Life Sci.63:2196-2212.","journal-title":"Cell. Mol. Life Sci."},{"key":"e_1_3_2_8_2","first-page":"86","volume":"16","year":"1973","unstructured":"Boulter, E. A., and G. Appleyard. 1973. Differences between extracellular and intracellular forms of poxvirus and their implications. Prog. Med. Virol.16:86-108.","journal-title":"Prog. Med. Virol."},{"key":"e_1_3_2_9_2","first-page":"63","volume":"16","year":"1957","unstructured":"Cockburn, W. C., R. M. Cross, A. W. Downie, K. R. Dumbell, C. Kaplan, D. McClean, and A. M. Payne. 1957. Laboratory and vaccination studies with dried smallpox vaccines. Bull. W. H. O.16:63-77.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","volume":"199","year":"2004","unstructured":"Combadiere, B., A. Boissonnas, G. Carcelain, E. Lefranc, A. Samri, F. Bricaire, P. Debre, and B. Autran. 2004. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J. Exp. Med.199:1585-1593.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","volume":"171","year":"2003","unstructured":"Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol.171:4969-4973.","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","volume":"4","year":"2004","unstructured":"Di Giulio, D. B., and P. B. Eckburg. 2004. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis.4:15-25.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.19.10684-10688.2003"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/427265","volume":"191","year":"2005","unstructured":"Edghill-Smith, Y., M. Bray, C. A. Whitehouse, D. Miller, E. Mucker, J. Manischewitz, L. R. King, M. Robert-Guroff, A. Hryniewicz, D. Venzon, C. Meseda, J. Weir, A. Nalca, V. Livingston, J. Wells, M. G. Lewis, J. Huggins, S. H. Zwiers, H. Golding, and G. Franchini. 2005. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J. Infect. Dis.191:372-381.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","volume":"11","year":"2005","unstructured":"Edghill-Smith, Y., H. Golding, J. Manischewitz, L. R. King, D. Scott, M. Bray, A. Nalca, J. W. Hooper, C. A. Whitehouse, J. E. Schmitz, K. A. Reimann, and G. Franchini. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med.11:740-747.","journal-title":"Nat. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","volume":"161","year":"1990","unstructured":"el-Ad, B., Y. Roth, A. Winder, Z. Tochner, T. Lublin-Tennenbaum, E. Katz, and T. Schwartz. 1990. The persistence of neutralizing antibodies after revaccination against smallpox. J. Infect. Dis.161:446-448.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2005.05.027","volume":"130","year":"2005","unstructured":"Eyal, O., U. Olshevsky, S. Lustig, N. Paran, M. Halevy, P. Schneider, G. Zomber, and P. Fuchs. 2005. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera. J. Virol. Methods130:15-21.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_18_2","unstructured":"Smallpox and its eradication. 1988"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.19.10230-10237.2004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","volume":"289","year":"2003","unstructured":"Frey, S. E., F. K. Newman, L. Yan, K. R. Lottenbach, and R. B. Belshe. 2003. Response to smallpox vaccine in persons immunized in the distant past. JAMA289:3295-3299.","journal-title":"JAMA"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","volume":"9","year":"2003","unstructured":"Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med.9:1131-1137.","journal-title":"Nat. Med."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","volume":"281","year":"1999","unstructured":"Henderson, D. A., T. V. Inglesby, J. G. Bartlett, M. S. Ascher, E. Eitzen, P. B. Jahrling, J. Hauer, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. Perl, P. K. Russell, K. Tonat, and the Working Group on Civilian Biodefense. 1999. Smallpox as a biological weapon: medical and public health management. JAMA281:2127-2137.","journal-title":"JAMA"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","volume":"177","year":"2006","unstructured":"Heraud, J. M., Y. Edghill-Smith, V. Ayala, I. Kalisz, J. Parrino, V. S. Kalyanaraman, J. Manischewitz, L. R. King, A. Hryniewicz, C. J. Trindade, M. Hassett, W. P. Tsai, D. Venzon, A. Nalca, M. Vaccari, P. Silvera, M. Bray, B. S. Graham, H. Golding, J. W. Hooper, and G. Franchini. 2006. Subunit recombinant vaccine protects against monkeypox. J. Immunol.177:2552-2564.","journal-title":"J. Immunol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","volume":"306","year":"2003","unstructured":"Hooper, J. W., D. M. Custer, and E. Thompson. 2003. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology306:181-195.","journal-title":"Virology"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.9.4433-4443.2004"},{"key":"e_1_3_2_26_2","first-page":"799","volume":"1","year":"1973","unstructured":"Huber, P. J. 1973. Robust regression: asymptotics, conjectures and Monte Carlo. Ann. Stat.1:799-821.","journal-title":"Ann. Stat."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/vim.1998.11.49","volume":"11","year":"1998","unstructured":"Ifrah, M., S. Stienlauf, M. Shoresh, and E. Katz. 1998. A tetrazolium-based colorimetric assay for titration of neutralizing antibodies against vaccinia virus. Viral Immunol.11:49-54.","journal-title":"Viral Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/oxfordjournals.aje.a114328","volume":"123","year":"1986","unstructured":"Jezek, Z., I. Arita, M. Mutombo, C. Dunn, J. H. Nakano, and M. Szczeniowski. 1986. Four generations of probable person-to-person transmission of human monkeypox. Am. J. Epidemiol.123:1004-1012.","journal-title":"Am. J. Epidemiol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jviromet.2008.02.009","volume":"150","year":"2008","unstructured":"Johnson, M. C., I. K. Damon, and K. L. Karem. 2008. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein. J. Virol. Methods150:14-20.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QAD.0b013e32802f7d7c","volume":"21","year":"2007","unstructured":"Kan, V. L., J. Manischewitz, L. R. King, and H. Golding. 2007. Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. AIDS21:521-524.","journal-title":"AIDS"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00353-08"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpedi.159.11.1022","volume":"159","year":"2005","unstructured":"Kile, J. C., A. T. Fleischauer, B. Beard, M. J. Kuehnert, R. S. Kanwal, P. Pontones, H. J. Messersmith, R. Teclaw, K. L. Karem, Z. H. Braden, I. Damon, A. S. Khan, and M. Fischer. 2005. Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003. Arch. Pediatr. Adolesc. Med.159:1022-1025.","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1016\/j.vaccine.2007.05.044","volume":"25","year":"2007","unstructured":"Kim, S. H., S. J. Choi, W. B. Park, H. B. Kim, N. J. Kim, M. D. Oh, and K. W. Choe. 2007. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine25:6287-6291.","journal-title":"Vaccine"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","volume":"280","year":"2001","unstructured":"Law, M., and G. L. Smith. 2001. Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology280:132-142.","journal-title":"Virology"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","year":"1972","unstructured":"Mack, T. M., J. Noble, Jr., and D. B. Thomas. 1972. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg.21:214-218.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","volume":"188","year":"2003","unstructured":"Manischewitz, J., L. R. King, N. A. Bleckwenn, J. Shiloach, R. Taffs, M. Merchlinsky, N. Eller, M. G. Mikolajczyk, D. J. Clanton, T. Monath, R. A. Weltzin, D. E. Scott, and H. Golding. 2003. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J. Infect. Dis.188:440-448.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/513968","volume":"175","year":"1997","unstructured":"McClain, D. J., S. Harrison, C. L. Yeager, J. Cruz, F. A. Ennis, P. Gibbs, M. S. Wright, P. L. Summers, J. D. Arthur, and J. A. Graham. 1997. Immunologic responses to vaccinia vaccines administered by different parenteral routes. J. Infect. Dis.175:756-763.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","volume":"339","year":"2005","unstructured":"Meseda, C. A., A. D. Garcia, A. Kumar, A. E. Mayer, J. Manischewitz, L. R. King, H. Golding, M. Merchlinsky, and J. P. Weir. 2005. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Virology339:164-175.","journal-title":"Virology"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1099\/vir.0.2008\/004440-0","volume":"89","year":"2008","unstructured":"Midgley, C. M., M. M. Putz, J. N. Weber, and G. L. Smith. 2008. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J. Gen. Virol.89:2992-2997.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.19.1.34-39.1978"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","volume":"344","year":"2006","unstructured":"Moss, B. 2006. Poxvirus entry and membrane fusion. Virology344:48-54.","journal-title":"Virology"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.7.3154-3157.2003"},{"key":"e_1_3_2_43_2","first-page":"756","volume":"65","year":"1977","unstructured":"Pattanayak, S., C. L. Sehgal, S. Choudhury, and P. Vijayan. 1977. Revaccination studies in children with graded potency of smallpox vaccines. Indian J. Med. Res.65:756-759.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","volume":"50","year":"1980","unstructured":"Payne, L. G. 1980. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol.50:89-100.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(05)70209-9","volume":"365","year":"2005","unstructured":"Poland, G. A. 2005. Smallpox vaccines: from first to second to third generation. Lancet365:362-363.","journal-title":"Lancet"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","volume":"23","year":"2005","unstructured":"Poland, G. A., J. D. Grabenstein, and J. M. Neff. 2005. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine23:2078-2081.","journal-title":"Vaccine"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0889-8561(03)00096-1","volume":"23","year":"2003","unstructured":"Poland, G. A., and J. M. Neff. 2003. Smallpox vaccine: problems and prospects. Immunol. Allergy Clin. N. Am.23:731-743.","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","volume":"12","year":"2006","unstructured":"P\u00fctz, M. M., C. M. Midgley, M. Law, and G. L. Smith. 2006. Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination. Nat. Med.12:1310-1315.","journal-title":"Nat. Med."},{"key":"e_1_3_2_49_2","first-page":"307","volume":"52","year":"1975","unstructured":"Sarkar, J. K., A. C. Mitra, and M. K. Mukherjee. 1975. The minimum protective level of antibodies in smallpox. Bull. W. H. O.52:307-311.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1086\/524751","volume":"46","year":"2008","unstructured":"Strikas, R. A., L. J. Neff, L. Rotz, J. Cono, D. Knutson, J. Henderson, and W. A. Orenstein. 2008. US civilian smallpox preparedness and response program, 2003. Clin. Infect. Dis.46(Suppl. 3):S157-S167.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","volume":"121","year":"2008","unstructured":"Taub, D. D., W. B. Ershler, M. Janowski, A. Artz, M. L. Key, J. McKelvey, D. Muller, B. Moss, L. Ferrucci, P. L. Duffey, and D. L. Longo. 2008. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am. J. Med.121:1058-1064.","journal-title":"Am. J. Med."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","volume":"7","year":"2005","unstructured":"Viner, K. M., and S. N. Isaacs. 2005. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees. Microbes Infect.7:579-583.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(78)80419-3","volume":"92","year":"1978","unstructured":"Virelizier, J. L., M. Hamet, J. J. Ballet, P. Reinert, and C. Griscelli. 1978. Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect. J. Pediatr.92:358-362.","journal-title":"J. Pediatr."},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/499957","volume":"42","year":"2006","unstructured":"Waibel, K. H., H. Golding, J. Manischewitz, L. R. King, M. Tuchscherer, R. L. Topolski, and D. S. Walsh. 2006. Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults. Clin. Infect. Dis.42:e16-e20.","journal-title":"Clin. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00109-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00109-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:41:50Z","timestamp":1627591310000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00109-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1128\/CVI.00109-09"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00109-09","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"2009-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}